Neurological disease drug developer Axial raised $37.3m from investors including Taiho Ventures while Best Buy is purchasing OSF and Legal & General-backed remote healthcare technology provider Current Health.

Funding US-based neurological disease therapy developer Axial Therapeutics closed a $37.3m series C round yesterday featuring Taiho Ventures, the investment arm of pharmaceutical firm Taiho. The round was co-led by OneVentures and University of Tokyo’s Innovation Platform Company and included Autism Impact Fund, Corundum Systems Biology, Longwood Fund, Seventure Partners and Domain Associates. Axial has…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.